Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
The global infantile spasms therapeutics market is growing at a slow pace. This is due to the increased availability of generic drugs and less approved therapies in the market and the less awareness of the disease and the available treatment options, especially in the low- and middle-income countries.The classification of Infantile Spasms Therapeutics includes Oral, Injection. The proportion of Injection in 2016 is about 45%, and the proportion of Oral in 2016 is about 55%.Based on application, the nitinol medical devices market is segmented into Hospital, Clinic and others. Clinic segment accounted for larger market share in terms of sales in 2016, Clinic segmented accounted for more than 45% of the market share in 2016.United States is the largest consumption place, with a consumption market share nearly 83% in 2016. Following United States, Europe is the second largest consumption place with the consumption market share of 12.6% in 2016.The US market is dominated by two approved products H.P. Acthar Gel (adrenocorticotropin hormone) and Sabril (vigabatrin). Sabril was the first drug to be approved by the Food and Drug Administration (FDA) in 2009 and H.P. Acthar Gel (adrenocorticotropin hormone) was approved for infantile spasms in 2010. Both have Orphan Drug Exclusivity (ODE) in the US.In the future, the Infantile Spasms Therapeutics will have a good future; the price fluctuation has relationship with the raw material. The technology will more mature and the industry is more dispersion.
This report elaborates on the current development of the Infantile Spasms Therapeutics industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Retrophin
Orphelia Pharma
Anavex Life Sciences
H Lundbeck
Mallinckrodt
Catalyst Pharmaceuticals
Valerion Therapeutics
GW Pharmaceuticals
By Type:
Oral
Injection
By Application:
Clinic
Hospital
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Infantile Spasms Therapeutics Market Overview 2018-2029
-
1.1 China Infantile Spasms Therapeutics Industry Development Overview
-
1.2 China Infantile Spasms Therapeutics Industry Development History
-
1.3 China Infantile Spasms Therapeutics Industry Market Size (2018-2029)
-
1.4 China Infantile Spasms Therapeutics Market Analysis by Type from Production Side
-
1.4.1 China Infantile Spasms Therapeutics Production Volume, Production Value and Growth Rate of Oral (2018-2029)
-
1.4.2 China Infantile Spasms Therapeutics Production Volume, Production Value and Growth Rate of Injection (2018-2029)
-
1.5 China Infantile Spasms Therapeutics Market Analysis by Application from Consumption End
-
1.5.1 China Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
1.5.2 China Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.6 China Infantile Spasms Therapeutics Market Analysis by Region
-
1.6.1 North China Infantile Spasms Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Infantile Spasms Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Infantile Spasms Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Infantile Spasms Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Infantile Spasms Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Infantile Spasms Therapeutics Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Infantile Spasms Therapeutics Market Size and Growth Rate from 2018-2029
Chapter 2 China Infantile Spasms Therapeutics Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Infantile Spasms Therapeutics Market Status and Competition at home and abroad in 2023
-
2.2.2 China Infantile Spasms Therapeutics Market Status and Competition Analysis in 2023
-
2.2.3 China Infantile Spasms Therapeutics Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Infantile Spasms Therapeutics Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Infantile Spasms Therapeutics Industry Development
Chapter 3 Infantile Spasms TherapeuticsIndustry Chain Analysis
-
3.1 Infantile Spasms Therapeutics Industry Chain
-
3.2 Infantile Spasms Therapeutics Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Infantile Spasms Therapeutics Market
-
3.3 Infantile Spasms Therapeutics Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Infantile Spasms Therapeutics Market
Chapter 4 China Infantile Spasms Therapeutics Market, by Type
-
4.1 China Infantile Spasms Therapeutics Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Infantile Spasms Therapeutics Total Production Volume and Growth Rate from Production Side
-
4.5 China Infantile Spasms Therapeutics Production Volume and Growth Rate, by Type
-
4.5.1 China Infantile Spasms Therapeutics Production Volume and Growth Rate of Oral
-
4.5.2 China Infantile Spasms Therapeutics Production Volume and Growth Rate of Injection
Chapter 5 China Infantile Spasms Therapeutics Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Infantile Spasms Therapeutics Total Market Size and Growth Rate from Consumption End
-
5.5 China Infantile Spasms Therapeutics Market Size and Growth Rate, by Application
-
5.5.1 China Infantile Spasms Therapeutics Market Size and Growth Rate of Clinic
-
5.5.2 China Infantile Spasms Therapeutics Market Size and Growth Rate of Hospital
Chapter 6 China Infantile Spasms Therapeutics Market, by Region
-
6.1 China Infantile Spasms Therapeutics Production Volume and Production Value, by Region
-
6.2 China Infantile Spasms Therapeutics Sales Volume and Sales Value, by Region
Chapter 7 North China Infantile Spasms Therapeutics Market Analysis
-
7.1 North China Infantile Spasms Therapeutics Market, by Type
-
7.2 North China Infantile Spasms Therapeutics Market, by Application
Chapter 8 Central China Infantile Spasms Therapeutics Market Analysis
-
8.1 Central China Infantile Spasms Therapeutics Market, by Type
-
8.2 Central China Infantile Spasms Therapeutics Market, by Application
Chapter 9 South China Infantile Spasms Therapeutics Market Analysis
-
9.1 South China Infantile Spasms Therapeutics Market, by Type
-
9.2 South China Infantile Spasms Therapeutics Market, by Application
Chapter 10 East China Infantile Spasms Therapeutics Market Analysis
-
10.1 East China Infantile Spasms Therapeutics Market, by Type
-
10.2 East China Infantile Spasms Therapeutics Market, by Application
Chapter 11 Northeast China Infantile Spasms Therapeutics Market Analysis
-
11.1 Northeast China Infantile Spasms Therapeutics Market, by Type
-
11.2 Northeast China Infantile Spasms Therapeutics Market, by Application
Chapter 12 Southwest China Infantile Spasms Therapeutics Market Analysis
-
12.1 Southwest China Infantile Spasms Therapeutics Market, by Type
-
12.2 Southwest China Infantile Spasms Therapeutics Market, by Application
Chapter 13 Northwest China Infantile Spasms Therapeutics Market Analysis
-
13.1 Northwest China Infantile Spasms Therapeutics Market, by Type
-
13.2 Northwest China Infantile Spasms Therapeutics Market, by Application
Chapter 14 Company Profiles
-
14.1 Retrophin
-
14.1.1 Retrophin Company Profile
-
14.1.2 Retrophin Infantile Spasms Therapeutics Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Orphelia Pharma
-
14.2.1 Orphelia Pharma Company Profile
-
14.2.2 Orphelia Pharma Infantile Spasms Therapeutics Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Anavex Life Sciences
-
14.3.1 Anavex Life Sciences Company Profile
-
14.3.2 Anavex Life Sciences Infantile Spasms Therapeutics Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 H Lundbeck
-
14.4.1 H Lundbeck Company Profile
-
14.4.2 H Lundbeck Infantile Spasms Therapeutics Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Mallinckrodt
-
14.5.1 Mallinckrodt Company Profile
-
14.5.2 Mallinckrodt Infantile Spasms Therapeutics Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Catalyst Pharmaceuticals
-
14.6.1 Catalyst Pharmaceuticals Company Profile
-
14.6.2 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Valerion Therapeutics
-
14.7.1 Valerion Therapeutics Company Profile
-
14.7.2 Valerion Therapeutics Infantile Spasms Therapeutics Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 GW Pharmaceuticals
-
14.8.1 GW Pharmaceuticals Company Profile
-
14.8.2 GW Pharmaceuticals Infantile Spasms Therapeutics Market Performance
-
14.8.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Infantile Spasms Therapeutics Industry Research Conclusions
-
15.2 Infantile Spasms Therapeutics Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Infantile Spasms Therapeutics Industry Market Size (2018-2029)
-
Figure China Infantile Spasms Therapeutics Production Volume, Production Value and Growth Rate of Oral (2018-2029)
-
Figure China Infantile Spasms Therapeutics Production Volume, Production Value and Growth Rate of Injection (2018-2029)
-
Figure China Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
Figure China Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure North China Infantile Spasms Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Central China Infantile Spasms Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure South China Infantile Spasms Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure East China Infantile Spasms Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Infantile Spasms Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Infantile Spasms Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Infantile Spasms Therapeutics Market Size and Growth Rate from 2018-2029
-
Figure Infantile Spasms Therapeutics Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Infantile Spasms Therapeutics Market Share by Type in 2018
-
Figure China Infantile Spasms Therapeutics Market Share by Type in 2023
-
Figure China Infantile Spasms Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Infantile Spasms Therapeutics Production Volume and Growth Rate of Oral (2018-2023)
-
Figure China Infantile Spasms Therapeutics Production Volume and Growth Rate of Injection (2018-2023)
-
Figure China Infantile Spasms Therapeutics Market Share by Application in 2018
-
Figure China Infantile Spasms Therapeutics Market Share by Application in 2023
-
Figure China Infantile Spasms Therapeutics Total Market Size and Growth Rate from Consumption End
-
Figure China Infantile Spasms Therapeutics Market Size and Growth Rate of Clinic (2018-2023)
-
Figure China Infantile Spasms Therapeutics Market Size and Growth Rate of Hospital (2018-2023)
-
Table China Infantile Spasms Therapeutics Production Volume by Region (2018-2023)
-
Table China Infantile Spasms Therapeutics Production Volume Share by Region (2018-2023)
-
Figure China Infantile Spasms Therapeutics Production Volume Share by Region (2018-2023)
-
Table China Infantile Spasms Therapeutics Production Value by Region (2018-2023)
-
Table China Infantile Spasms Therapeutics Production Value Share by Region (2018-2023)
-
Figure China Infantile Spasms Therapeutics Production Value Share by Region (2018-2023)
-
Table China Infantile Spasms Therapeutics Sales Volume by Region (2018-2023)
-
Table China Infantile Spasms Therapeutics Sales Volume Share by Region (2018-2023)
-
Figure China Infantile Spasms Therapeutics Sales Volume Share by Region (2018-2023)
-
Table China Infantile Spasms Therapeutics Sales Value by Region (2018-2023)
-
Table China Infantile Spasms Therapeutics Sales Value Share by Region (2018-2023)
-
Figure China Infantile Spasms Therapeutics Sales Value Share by Region (2018-2023)
-
Table North China Infantile Spasms Therapeutics Production Volume by Type (2018-2023)
-
Table North China Infantile Spasms Therapeutics Production Volume Share by Type (2018-2023)
-
Figure North China Infantile Spasms Therapeutics Production Volume Share by Type (2018-2023)
-
Table North China Infantile Spasms Therapeutics Sales Volume by Application (2018-2023)
-
Table North China Infantile Spasms Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure North China Infantile Spasms Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Central China Infantile Spasms Therapeutics Production Volume by Type (2018-2023)
-
Table Central China Infantile Spasms Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Central China Infantile Spasms Therapeutics Production Volume Share by Type (2018-2023)
-
Table Central China Infantile Spasms Therapeutics Sales Volume by Application (2018-2023)
-
Table Central China Infantile Spasms Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Central China Infantile Spasms Therapeutics Sales Volume Share by Application (2018-2023)
-
Table South China Infantile Spasms Therapeutics Production Volume by Type (2018-2023)
-
Table South China Infantile Spasms Therapeutics Production Volume Share by Type (2018-2023)
-
Figure South China Infantile Spasms Therapeutics Production Volume Share by Type (2018-2023)
-
Table South China Infantile Spasms Therapeutics Sales Volume by Application (2018-2023)
-
Table South China Infantile Spasms Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure South China Infantile Spasms Therapeutics Sales Volume Share by Application (2018-2023)
-
Table East China Infantile Spasms Therapeutics Production Volume by Type (2018-2023)
-
Table East China Infantile Spasms Therapeutics Production Volume Share by Type (2018-2023)
-
Figure East China Infantile Spasms Therapeutics Production Volume Share by Type (2018-2023)
-
Table East China Infantile Spasms Therapeutics Sales Volume by Application (2018-2023)
-
Table East China Infantile Spasms Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure East China Infantile Spasms Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Northeast China Infantile Spasms Therapeutics Production Volume by Type (2018-2023)
-
Table Northeast China Infantile Spasms Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Northeast China Infantile Spasms Therapeutics Production Volume Share by Type (2018-2023)
-
Table Northeast China Infantile Spasms Therapeutics Sales Volume by Application (2018-2023)
-
Table Northeast China Infantile Spasms Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Infantile Spasms Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Southwest China Infantile Spasms Therapeutics Production Volume by Type (2018-2023)
-
Table Southwest China Infantile Spasms Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Southwest China Infantile Spasms Therapeutics Production Volume Share by Type (2018-2023)
-
Table Southwest China Infantile Spasms Therapeutics Sales Volume by Application (2018-2023)
-
Table Southwest China Infantile Spasms Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Infantile Spasms Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Northwest China Infantile Spasms Therapeutics Production Volume by Type (2018-2023)
-
Table Northwest China Infantile Spasms Therapeutics Production Volume Share by Type (2018-2023)
-
Figure Northwest China Infantile Spasms Therapeutics Production Volume Share by Type (2018-2023)
-
Table Northwest China Infantile Spasms Therapeutics Sales Volume by Application (2018-2023)
-
Table Northwest China Infantile Spasms Therapeutics Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Infantile Spasms Therapeutics Sales Volume Share by Application (2018-2023)
-
Table Retrophin Company Profile
-
Table Retrophin Infantile Spasms Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Orphelia Pharma Company Profile
-
Table Orphelia Pharma Infantile Spasms Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Anavex Life Sciences Company Profile
-
Table Anavex Life Sciences Infantile Spasms Therapeutics Revenue, Price and Gross (2018-2023)
-
Table H Lundbeck Company Profile
-
Table H Lundbeck Infantile Spasms Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Mallinckrodt Company Profile
-
Table Mallinckrodt Infantile Spasms Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Catalyst Pharmaceuticals Company Profile
-
Table Catalyst Pharmaceuticals Infantile Spasms Therapeutics Revenue, Price and Gross (2018-2023)
-
Table Valerion Therapeutics Company Profile
-
Table Valerion Therapeutics Infantile Spasms Therapeutics Revenue, Price and Gross (2018-2023)
-
Table GW Pharmaceuticals Company Profile
-
Table GW Pharmaceuticals Infantile Spasms Therapeutics Revenue, Price and Gross (2018-2023)
-
